Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -53.50%2.09B | -88.53%113.52M | -53.27%762.59M | -38.67%613.6M | -30.93%595.76M | 33.15%4.48B | 47.07%989.75M | 28.90%1.63B | 2.60%1B | 89.97%862.5M |
Cost of revenue | -32.70%2.53B | -86.70%118.05M | -3.91%1.39B | -36.26%499.21M | -18.75%523.93M | 49.28%3.76B | 90.02%887.28M | 45.21%1.45B | 4.53%783.14M | 109.62%644.84M |
Gross profit | -162.10%-447.58M | -104.42%-4.53M | -443.19%-629.26M | -47.36%114.39M | -67.00%71.82M | -14.88%720.77M | -50.27%102.47M | -31.70%183.36M | -3.79%217.29M | 48.69%217.66M |
Operating expense | 109.50%1.39B | 274.74%842M | 20.04%175.34M | 44.26%212.71M | 10.96%162.59M | 8.04%664.76M | 37.45%224.69M | -3.96%146.08M | -9.39%147.46M | 6.95%146.54M |
Operating profit | -3,385.70%-1.84B | -592.60%-846.53M | -2,258.26%-804.6M | -240.80%-98.32M | -227.64%-90.77M | -75.80%56.01M | -387.06%-122.23M | -67.96%37.28M | 10.64%69.83M | 658.76%71.12M |
Net non-operating interest income (expenses) | -302.69%-27.11M | -533.40%-12.97M | -321.55%-8.53M | -92.27%-3.06M | -138.35%-2.55M | -66.72%-6.73M | -85.68%-2.05M | -150.37%-2.02M | -64.46%-1.59M | 7.77%-1.07M |
Non-operating interest income | -14.12%1.55M | -26.34%330K | -18.30%366K | -9.91%409K | -2.19%446K | 19.76%1.81M | -0.22%448K | -25.21%448K | -0.87%454K | 22,700.00%456K |
Non-operating interest expense | 235.68%28.66M | 432.93%13.3M | 259.94%8.89M | 69.60%3.47M | 96.33%2.99M | 53.95%8.54M | 60.82%2.5M | 75.62%2.47M | 43.48%2.05M | 31.35%1.53M |
Net investment income | 0 | 0 | -59.67%198K | |||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 21.67M | 0 | 0 | 0 | 21.67M | 0 | 0 | 0 | 0 | 0 |
Income from associates and other participating interests | 76.48%-1.13M | 75.09%-73K | 98.56%-14K | -5.51%-1.03M | 99.50%-13K | -4.82M | -293K | -970K | -980K | -2.58M |
Special income (charges) | -12,992.67%-1.06B | -27,451.78%-707.86M | -11,190.76%-350.36M | -42.46%8.2M | -72.02%2.59M | 3.16M | ||||
Less:Other special charges | 31.29%-2.2M | 59.54%-1.05M | --0 | ---- | ---- | ---3.2M | ---2.59M | ---2.16M | ---- | ---- |
Less:Write off | 21,285.36%1.06B | --708.91M | 35,135.70%350.36M | ---- | ---- | 64.91%-5M | --0 | ---1M | ---- | ---- |
Other non-operating income (expenses) | -8,342.61%-122.84M | -48,112.36%-124.35M | -70.90%39K | 38.04%225K | 162.06%1.25M | -313.34%-1.46M | 130.80%259K | -87.24%134K | -58.94%163K | -2,746.05%-2.01M |
Income before tax | -6,011.88%-3.03B | -1,297.82%-1.7B | -3,163.01%-1.15B | -244.60%-101.04M | -207.25%-70.41M | -74.69%51.2M | -1,398.22%-121.92M | -67.77%37.58M | 11.72%69.88M | 376.46%65.66M |
Income tax | -96.48%2.08M | -89.23%1.56M | -98.26%172K | -99.38%112K | -98.61%232K | 287.61%59.06M | 148.06%14.51M | -63.89%9.87M | 8.11%17.97M | 1,042.89%16.71M |
Net income | -38,419.43%-3.03B | -1,150.32%-1.71B | -4,255.09%-1.15B | -294.87%-101.15M | -244.33%-70.65M | -104.20%-7.86M | -444.68%-136.42M | -68.96%27.71M | 13.02%51.91M | 297.36%48.95M |
Net income continuous operations | -38,419.43%-3.03B | -1,150.31%-1.71B | -4,255.09%-1.15B | -294.87%-101.15M | -244.33%-70.65M | -104.20%-7.86M | -444.68%-136.43M | -68.96%27.71M | 13.02%51.91M | 297.36%48.95M |
Noncontrolling interests | 0 | 0 | ||||||||
Net income attributable to the company | -38,419.43%-3.03B | -1,150.32%-1.71B | -4,255.09%-1.15B | -294.87%-101.15M | -244.33%-70.65M | -104.20%-7.86M | -444.68%-136.42M | -68.96%27.71M | 13.02%51.91M | 297.36%48.95M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -38,419.43%-3.03B | -1,150.32%-1.71B | -4,255.09%-1.15B | -294.87%-101.15M | -244.33%-70.65M | -104.20%-7.86M | -444.68%-136.42M | -68.96%27.71M | 13.02%51.91M | 297.36%48.95M |
Gross dividend payment | ||||||||||
Basic earnings per share | -37,578.43%-576.48 | -1,092.05%-318.04 | -4,256.75%-224.88 | -294.49%-19.76 | -244.05%-13.8 | -104.17%-1.53 | -444.04%-26.68 | -69.09%5.41 | 12.64%10.16 | 296.69%9.58 |
Diluted earnings per share | -37,578.43%-576.48 | -1,092.05%-318.04 | -4,264.44%-224.88 | -295.06%-19.76 | -244.35%-13.8 | -104.18%-1.53 | -444.04%-26.68 | -69.04%5.4 | 12.81%10.13 | 297.51%9.56 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |